drugset / Trial / NCT00556673

Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma

NCT00556673

Phase 2 Completed 31 enrolled Novartis Merck Sharp & Dohme LLC · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is designed to evaluate the bronchodilatory efficacy of indacaterol maleate 500 μg/mometasone furoate 400 μg via the Twisthaler® device in adult patients with persistent asthma.

Timeline

Start
2007-10
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 250 ug Inhaled
Subject Indacaterol Other / unclassified 250 ug Inhaled
Subject Mometasone Other / unclassified 200 ug Inhaled
Subject Salmeterol Other / unclassified 50 ug Inhaled

Indications